624
Views
16
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

, , , , , & show all
Pages 216-217 | Received 15 Jul 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jeanny B. Aragon-Ching, Yang-Min Ning, Clara C. Chen, Lea Latham, Jean-Pierre Guadagnini, James L. Gulley, Philip M. Arlen, John J. Wright, Howard Parnes, William D. Figg & William L. Dahut. (2009) Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents. Cancer Investigation 27:2, pages 221-226.
Read now
Cinzia Ortega, Filippo Montemurro, Roberto Faggiuolo, Roberto Vormola, Daniela Nanni, Franco Goia, Marco Ottavio Gilardino & Massimo Aglietta. (2007) Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis. Acta Oncologica 46:5, pages 664-668.
Read now
Fergal C. Kelleher, Malachi McKenna, Conor Collins, Garrett Brady, Ian Collins & John Crown. (2007) Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality. Acta Oncologica 46:5, pages 702-704.
Read now

Articles from other publishers (13)

Janson Trieu, Mark Chang, Vanessa Rojas, Neilmegh Varada, Yen Cao, Michael Anderson & Nicholas J. Vogelzang. (2022) Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis. Clinical Genitourinary Cancer 20:5, pages 399-403.
Crossref
Petra Rugani, Christian Walter, Barbara Kirnbauer, Stephan Acham, Yvonne Begus-Nahrman & Norbert Jakse. (2016) Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma. Dentistry Journal 4:4, pages 32.
Crossref
Athanasios Zavras. 2015. Genomics, Personalized Medicine and Oral Disease. Genomics, Personalized Medicine and Oral Disease 311 331 .
Mauro Capocci, Umberto Romeo, Fabio Cocco, Isabella Bignozzi, Susanna Annibali & Livia Ottolenghi. (2014) The “CROMa” Project: A Care Pathway for Clinical Management of Patients with Bisphosphonate Exposure. International Journal of Dentistry 2014, pages 1-8.
Crossref
Sebastian Kühl, Christian Walter, Stephan Acham, Roland Pfeffer & J. Thomas Lambrecht. (2012) Bisphosphonate-related osteonecrosis of the jaws – A review. Oral Oncology 48:10, pages 938-947.
Crossref
Janet E. Brown & Sheryl Sim. (2010) Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer. Neoplasia 12:9, pages 685-696.
Crossref
Pongthorn Narongroeknawin, Maria I. Danila, Lewis G. Humphreys Jr, Andrei Barasch & Jeffrey R. Curtis. (2010) Bisphosphonate-associated osteonecrosis of the jaw,with healing after teriparatide:a review of the literature and a case report. Special Care in Dentistry 30:2, pages 77-82.
Crossref
Pinelopi Kleio Palaska, Vassiliki Cartsos & Athanasios I. Zavras. (2009) Bisphosphonates and Time to Osteonecrosis Development. The Oncologist 14:11, pages 1154-1166.
Crossref
Tim Van den Wyngaert, Manon T. Huizing, Eric Fossion & Jan B. Vermorken. (2009) Bisphosphonates in Oncology: Rising Stars or Fallen Heroes. The Oncologist 14:2, pages 181-191.
Crossref
Carlina V. Albanese & Roberto PassarielloPaolo Tonelli, Leila Brancato, Marco Duvina, Christian Viviani & Alberto Borgioli. 2009. Osteoporosi e malattie metaboliche dell’osso. Osteoporosi e malattie metaboliche dell’osso 531 535 .
Mario H. ABU-ID, Patrick H. WARNKE, Joachim GOTTSCHALK, Ingo SPRINGER, Jörg WILTFANG, Yahya ACIL, Paul A.J. RUSSO & Thomas KREUSCH. (2008) “Bis-phossy jaws” – High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery 36:2, pages 95-103.
Crossref
Tim Van den Wyngaert, Manon T Huizing & Jan B Vermorken. (2007) Osteonecrosis of the jaw related to the use of bisphosphonates. Current Opinion in Oncology 19:4, pages 315-322.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.